More than 40 companies are now engaged in bioprospecting in the Arctic. Hannah Hoag gauges the biotech potential buried beneath the ice and snow.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Gore, A. & Store, J.G., Co-chairs' summary for “Melting ices: regional drama, global wake-up call” conference, Tromsø, Norway, April 28, 2009. <http://arctic-council.org/filearchive/summary.pdf>
Leary, D. UNU-IAS Report: Bioprospecting in the Arctic (UNU-IAS, Yokohama, Japan; September 2008). <http://www.ias.unu.edu/sub_page.aspx?catID=111&ddlID=674>
Newman, D.J. et al. J. Nat. Prod. 66, 1022–1037 (2003).
Bredholt, H. et al. Mar. Drugs 6, 12–24 (2008).
Prudhomme, J. et al. PLoS One 3, e2335 (2008).
Baltz, R. Microbe 2, 125–131 (2007).
Zotchev, S.B. et al. WIPO patent WO/2001/059126 (2001)
Zaitsev, G. M. et al. Appl. Microbiol. Biotechnol. 76, 1092–1102 (2007).
UNCLOS Convention on the Law of the Sea, November 1994. <http://www.un.org/Depts/los/convention_agreements/texts/unclos/closindx.htm>
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hoag, H. The cold rush. Nat Biotechnol 27, 690–692 (2009). https://doi.org/10.1038/nbt0809-690
Issue Date:
DOI: https://doi.org/10.1038/nbt0809-690